Literature DB >> 21178407

Insight into innovative approaches to battle Acinetobacter baumannii infection therapy struggles.

Luis A Actis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21178407      PMCID： PMC3080204          DOI： 10.4161/viru.1.1.10210

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  8 in total

1.  [Septicemic state caused by Acinetobacter lwoffi].

Authors:  J MARTY; P NAVARRANNE; J PERROT; L MOLLARET; R CHAMFEUIL
Journal:  Bull Mem Soc Med Hop Paris       Date:  1960 Dec 2-9

2.  Photodynamic therapy for Acinetobacter baumannii burn infections in mice.

Authors:  Tianhong Dai; George P Tegos; Zongshun Lu; Liyi Huang; Timur Zhiyentayev; Michael J Franklin; David G Baer; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii.

Authors:  Chiara Brachelente; Dominique Wiener; Yasminda Malik; Daniela Huessy
Journal:  Vet Dermatol       Date:  2007-12       Impact factor: 1.589

4.  Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.

Authors:  Katrina DeLeon; Fredrik Balldin; Chase Watters; Abdul Hamood; John Griswold; Sunil Sreedharan; Kendra P Rumbaugh
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

5.  Two cases of necrotizing fasciitis due to Acinetobacter baumannii.

Authors:  Angella Charnot-Katsikas; Amir H Dorafshar; Joyce K Aycock; Michael Z David; Stephen G Weber; Karen M Frank
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 7.  Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii.

Authors:  Daniel L Zimbler; William F Penwell; Jennifer A Gaddy; Sharon M Menke; Andrew P Tomaras; Pamela L Connerly; Luis A Actis
Journal:  Biometals       Date:  2009-01-07       Impact factor: 2.949

8.  The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia.

Authors:  Matthieu Eveillard; Christophe Soltner; Marie Kempf; Jean-Paul Saint-André; Carole Lemarié; Catherine Randrianarivelo; Harald Seifert; Michel Wolff; Marie-Laure Joly-Guillou
Journal:  J Infect       Date:  2009-09-11       Impact factor: 6.072
  8 in total
  3 in total

1.  Diabetic murine models for Acinetobacter baumannii infection.

Authors:  Guanpingsheng Luo; Brad Spellberg; Teclegiorgis Gebremariam; Michael Bolaris; Hongkyu Lee; Yue Fu; Samuel W French; Ashraf S Ibrahim
Journal:  J Antimicrob Chemother       Date:  2012-03-02       Impact factor: 5.790

2.  Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Authors:  Steven E Fiester; Brock A Arivett; Amber C Beckett; Benjamin R Wagner; Emily J Ohneck; Robert E Schmidt; Jennifer T Grier; Luis A Actis
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Authors:  Steven E Fiester; Brock A Arivett; Robert E Schmidt; Amber C Beckett; Tomislav Ticak; Mary V Carrier; Rajarshi Ghosh; Emily J Ohneck; Maeva L Metz; Marlo K Sellin Jeffries; Luis A Actis
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.